SCHEMBL15034541

SCHEMBL15034541

Cc1cc(-c2cn(-c3ccc(F)cc3)c(CC(=O)N3CCN(c4cccnn4)CC3)n2)ccc1F

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 15/20 0.64
SLC6A7 Q99884 1/20 0.39
FAAH O00519 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15034536 0.92 GRM5 (0.54) GRM5SLC6A7FAAH
SCHEMBL15034514 0.91 GRM5 (0.49) GRM5SLC6A7FAAH
SCHEMBL15034516 0.90 GRM5 (0.50) GRM5SLC6A7
SCHEMBL15034540 0.89 GRM5 (0.70) GRM5
SCHEMBL15034542 0.87 GRM5 (0.61) GRM5SLC6A7
SCHEMBL15034524 0.86 L3MBTL1 (0.49) GRM5SLC6A7
SCHEMBL15034558 0.84 GRM5 (0.68) GRM5
SCHEMBL15034544 0.83 GRM5 (0.64) GRM5
SCHEMBL15034545 0.83 GRM5 (0.53) GRM5
SCHEMBL15025664 0.83 GRM5 (0.90) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937176-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-01-20 US disclosed
US-8937176-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-01-20 US disclosed
US-20130158038-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158038-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158038-A1 NOVEL COMPOUNDS GRM5, GRIN1, GRM1 GRM5 1/4885SLC6A7 1370/4885FAAH 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.